News

The growing prevalence of diabetes, primarily due to obesity, aging populations, and sedentary lifestyles, is a key factor ...
New research indicates GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...
The escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...
Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...
A study from the Arkansas Agricultural Experiment Station finds that GLP-1 medications, such as Ozempic and Wegovy, are ...
GLP-1s improve different mechanisms involved in insulin resistance, including delaying gastric emptying (which slows down ...
Mounjaro explained as 'All About That Bass' singer Meghan Trainor admits to using it amid major weight loss transformation.
Five researchers have been jointly awarded one of this year's Breakthrough Prizes in Life Sciences for their contributions to the development of Ozempic-style drugs.
GLP-1s improve different mechanisms involved in insulin resistance, including delaying gastric emptying (which slows down ...
Studies show that GLP-1 agonists can help patients lose 5-15% of their body weight when combined with diet and exercise.